Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ KLF7 Polyclonal Antibody

Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA556487
Description
Immunogen sequence: EAAICEKSSA VDILLSRDKL LSETCLSLQP ASSSLDSYTA VNQAQLNAVT SLTPPSSPEL SRHLVKTSQT LSAVDGTVTL KLVAKKAALS SVKVGGVATA AAAVTAAGAV KSGQSDSDQG G Highest antigen sequence identity to the following orthologs: Mouse - 95%, Rat - 95%.
The protein encoded by this gene is a member of the Kruppel-like transcriptional regulator family. Members in this family regulate cell proliferation, differentiation and survival and contain three C2H2 zinc fingers at the C-terminus that mediate binding to GC-rich sites. This protein may contribute to the progression of type 2 diabetes by inhibiting insulin expression and secretion in pancreatic beta-cells and by deregulating adipocytokine secretion in adipocytes. A pseudogene of this gene is located on the long arm of chromosome 3. Alternative splicing results in multiple transcript variants.
Specifications
KLF7 | |
Polyclonal | |
Unconjugated | |
Klf7 | |
9830124P08Rik; Klf7; Krueppel-like factor 7; Kruppel like factor 7; Kruppel-like factor 7 (ubiquitous); Ubiquitous krueppel-like factor; ubiquitous Kruppel-like factor; ubiquitous Kruppel-like transcription factor; UKLF | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
8609 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Immunocytochemistry | |
0.2 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
O75840 | |
Klf7 | |
Recombinant protein corresponding to Human KLF7. Recombinant protein control fragment (Product #RP-100752). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction